日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

New US drugs improve health

By Wang Xiaodong | China Daily | Updated: 2018-05-19 14:21
Share
Share - WeChat
An employee stacks Johnson& Johnson Neosporin brand boxes on the production line at the J&J consumer healthcare products plant in Lititz, Pennsylvania, the United States. [Photo/Agencies]

New drugs developed by pharmaceutical companies from the United States have played an important role in improving healthcare for Chinese, according to China Association of Enterprises with Foreign Investment.

International pharmaceutical companies, including those from the US, have kept investing in research and development of new drugs in China, which has also contributed to improved innovation and research capabilities for domestic pharmaceutical companies, said Zuo Yuzeng, chief for communications at the association's R& D-based Pharmaceutical Association Committee.

The committee is comprised of 40 international companies with pharmaceutical research and development capabilities, including 12 from the US, such as MSD and Xian Janssen, he said.

"The companies have brought many patent drugs to Chinese patients. Many were not available in China before, and have contributed to helping patients relieve pain and prolong life," the committee said.

A recent new drug that was introduced to China was Sirturo, developed by Xian Janssen Pharmaceutical, a subsidiary of US company Johnson& Johnson.

The drug, the first new medication for tuberculosis worldwide for the past 45 years, has been administered in China since Feb 24, and initial results showed it is effective for patients with multidrug-resistant TB, according to Wang Bin, deputy head of disease control and prevention for the National Health Commission.

Asgar Rangoonwala, president of Xian Janssen, said the drug is now being used at 16 hospitals nationwide in a trial program.

In April, China Drug Administration approved a nine-way HPV vaccine, which works against up to nine types of HPV and was developed by US company MSD. A similar vaccine, which was also developed by the company and works against four types of HPV, was approved by the administration in May last year.

Previously, no vaccines were available on the Chinese mainland to effectively prevent cervical cancer, the second most common cancer among Chinese women aged 15 to 44 after breast cancer, except a two-way HPV vaccine, driving many women to Hong Kong to receive such vaccines.

International pharmaceutical companies have also contributed to improved capacities in innovation and research of domestic companies through increasing research and development in China, partnering with domestic research institutes and providing training, according to R & D-based Pharmaceutical Association Committee.

"Some domestic international companies in recent years have been developing fast and they are catching up," said Zuo from the committee.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 成年免费大片黄在线观看岛国 | 国产精品成人不卡在线观看 | 高校处世王| 国产电影一区二区 | 91偷拍精品一区二区三区 | 99热在线精品观看 | 亚洲精品久久久久综合中文字幕 | 蜜桃网在线观看 | 国产在线视频网址 | 欧美天天在线 | www.ouchn.com| 色黄网站aaaaaa级毛片 | 久久www免费人成看片高清 | 亚洲一区免费在线观看 | 国产人成精品综合欧美成人 | 久草精品视频在线观看 | 欧美日韩在线电影 | 狠狠操伊人| 国产日韩欧美视频 | 91视频免费观看高清观看完整 | 国产精品1区2区3区 亚洲国产aⅴ成人精品无吗 | 日本黄色一级视频 | 香蕉久久夜色精品国产小优 | 精品二区 | 亚洲另类天天更新影院在线观看 | 91在线看| 成年人在线播放 | 亚洲看片| 免费国产自久久久久三四区久久 | 国产精品2020观看久久 | 精品欧美| 6月婷婷 | 日韩精品一区二区三区 | 日韩99| 欧美大片在线看免费观看 | 国产酒店视频 | 成人欧美s视频在线观看 | 在线视频三级 | 久久99国产精一区二区三区 | 久九九精品免费视频 | www.男插女b免费视频 |